Evidence-Based Oncology

Call for Papers

The US National Library of Medicine defines evidence-based medicine as “the process of systematically finding, appraising, and using contemporaneous research findings as the basis of clinical decisions. Evidence-based medicine asks questions, finds and appraises relevant data, and harnesses that information for everyday clinical practice.”

On this basis, Evidence-Based Oncology (EBO) seeks high-quality commentaries and original research reports on cutting-edge clinical, pharmacoeconomic, and regulatory topics in cancer care. The objective is to provide patients, clinicians, payers, health plans, and the pharmaceutical community, evidence-based information to aid care decisions. The editors are especially interested in papers that promote dialogue and facilitate communication among stakeholders and healthcare policy makers that would potentially impact the efficiency and outcomes in cancer care. EBO™ regularly publishes articles that cover:

  • Drug pipelines
  • Clinical trial results
  • Diagnostic advances
  • Targeted therapy
  • Biomarker-aided personalized medicine
  • Health policy (private, Medicare, and Medicaid)
  • Regulatory policies
  • Quality of care
  • Patient engagement

We would like to highlight that EBO would be an ideal platform to publish “orphan scientific findings,” which may be important but not extensive enough to support a complete article for publication in a peer-reviewed journal.

EBO™ is open access, which expands the reach of the published data. The contributing authors are not required to cover publication costs. We are an indexed publication but we do not undergo a peer-review process.

If you wish to submit to EBO, or have further questions, please contact  Managing Editor Mary K. Caffrey, mcaffrey@ajmc.com, 609-716-7777 x144.